MPH Health Care AG

FSX:93M1.DE

25.8 (EUR) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q22013 Q42013 Q22012 Q42012 Q32012 Q22012 Q1
Revenue -3.6467.1520.116.5830.2673.7270.634-9.3130.2936.471-0.161-12.85857.70426.4317.382.8486.042150.178112.708101.672117.576114.46112.38453.20553.20549.64949.649
Cost of Revenue 0-26.937-0.2310.0350.0170.140.2080.2680.1660.2720.06900006.8936.876133.727102.488.792108.668105.559104.43950.12950.12942.75342.753
Gross Profit -3.64634.0890.3416.5490.253.5870.426-9.5810.1266.199-0.23-12.85857.70426.4317.38-4.045-0.83416.45110.30812.8818.9088.97.9463.0763.0766.8966.896
Gross Profit Ratio 14.7663.0940.9950.9380.9620.6721.0290.4320.9581.4271111-1.42-0.1380.110.0910.1270.0760.0780.0710.0580.0580.1390.139
Reseach & Development Expenses 00.0940.0410.040.040.040.040.040.0350.01100000000000000000
General & Administrative Expenses 00.6710.4710.5640.4230.5260.3980.4340.4070.4930.4410.7660.380.8560.321000000000000
Selling & Marketing Expenses 0-0.659-0.464-0.55-0.413-0.514-0.39-0.426-0.398-0.48400000000000000000
SG&A 00.6710.4710.5640.0110.0120.0080.0080.0090.0090.4410.7660.380.8560.3210.1420.4164.8063.526.47905.81800000
Other Expenses 79.3870-00-0-000-00-18.1790000000000000000
Operating Expenses 79.38711.56115.78235.70536.75121.6690.58935.68638.7151.74318.1796.1851.028.1749.69951.64413.56867.7235.2038.1492.7282.0942.2692.5112.511-1.58-1.58
Operating Income 75.74146.792-15.59466.064-35.995-32.41323.457-37.723-32.65629.313-18.409-13.60957.33725.9777.0829.396-1.5048.0235.1044.7326.186.8065.6772.2182.2185.3265.326
Operating Income Ratio -20.7726.542-141.34610.035-135.034-8.69636.9844.051-111.614.53114.3261.0580.9940.9830.963.299-0.2490.0530.0450.0470.0530.0590.0510.0420.0420.1070.107
Total Other Income Expenses Net -0.24-0.391-0.05-0.054-0-000-00-0.248-5.681-0.7058.508-9.44851.87921.38574.974-0.823-0.861-0.743-0.705-0.5173.0113.011-0.323-0.323
Income Before Tax 75.546.401-15.64466.009-0-00-0-00-18.658-19.28956.63134.485-2.36661.27519.88182.9974.2813.8715.4386.1015.165.2295.2295.0035.003
Income Before Tax Ratio -20.7066.488-141.79910.027-0-000-00115.8691.50.9811.305-0.32121.5153.290.5530.0380.0380.0460.0530.0460.0980.0980.1010.101
Income Tax Expense 0.9760.461-0.2380.9-0-00-0-00-0.420.4070.7240.4320.1680.8250.2651.1821.9960.0320.8882.8410.9280.8960.8960.1350.135
Net Income 74.52444.951-15.40665.1094.2814.2814.2814.2814.2814.281-18.237-18.88255.90734.053-2.19860.4519.61680.3032.2850.44.552.2144.2323.8733.8733.4843.484
Net Income Ratio -20.4386.285-139.6469.8916.0621.1496.75-0.4614.6330.662113.2591.4690.9691.288-0.29821.2253.2470.5350.020.0040.0390.0190.0380.0730.0730.070.07
EPS 17.4110.5-3.615.21111110.99-4.26-4.413.18.17-0.514.064.618.760.530.0951.120.551.060.230.2300
EPS Diluted 17.4110.5-3.615.21111110.99-4.26-4.413.18.17-0.514.064.618.760.530.0951.120.551.040.230.2300
EBITDA 75.74846.804-15.58766.078-0.541-0.5630.33-0.546-0.5260.394-18.406-13.57457.34725.9887.09215.405-1.49418.0255.9985.6647.0777.7156.492.552.555.5015.501
EBITDA Ratio -20.7746.544-141.28110.037-2.03-0.1510.5210.059-1.7960.061114.311.0560.9940.9830.9615.409-0.2470.120.0530.0560.060.0670.0580.0480.0480.1110.111